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1. Introduction 
Cutaneus malignant melanoma (MM) is a highly malignant tumour of the skin and is 
responsible for more deaths than any other skin cancer (Imko-Walczuk et al., 2009). 
Melanocytes originate from the neural crest and in contrast to Langerhans' cells are located 
amongst the basal layer of the epidermis, hair bulb, eyes, ears, and meninges (Bandarchi et 
al., 2010; Fitzpatrick, 1971; Nordlund & Boissy, 2001). The pigmentary system of the skin is a 
complex set of reactions with many potential sites for dysfunction (Grichnik, 1998). Melanin 
pigment is produced by melanocytes in their specific cytoplasmic organelles called 
melanosomes. MM arises from the malignant transformation of melanocytes at the dermal-
epidermal junction or from the nevomelanocytes of melanocytic nevi that become invasive 
and may metastasise. 
The incidence of MM has been increasing in white populations. Although MM comprises less 
than 5% of malignant skin tumours; however, it is responsible for almost 60% of lethal skin 
neoplasia. With increased life expectancy of the elderly population, melanoma will be a public 
health challenge (Riker et al., 2010). Increased incidence of melanoma is partly due to early 
detection (thin melanomas) and partly due to true increase of incidence. Despite the increase in 
the incidence of melanoma, the prognosis has been improving due to earlier diagnosis of thin 
melanomas and hence in a curable stage (MacKie, 2000). The incidence of melanoma is equal 
in men and women and uncommon in children although there are reports that the incidence 
may be higher in women. A typical patient is usually a Caucasian adult in the 4th decade of 
life with lesion on the back and leg in male and female, respectively. One typical study 
revealed that the most common sites in decreasing order are the trunk (43.5%), extremities 
(33.9%), acral sites (11.9%), and head and neck (10.7%) (Bandarchi et al., 2010). 
There is a complex interaction of environmental (exogenous) and endogenous factors. Up to 
65% of MM is sun-related (Whiteman & Green, 1999). It is now widely accepted that the 
major environmental risk factor for the development of primary cutaneous melanoma is 
Ultraviolent (UV) radiation, which can be subdivided into UVA, UVB, and UVC. UV 
radiation in sunlight is cytotoxic and, in over dosages, clearly detrimental cells die in 
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apoptosis („sunburn cells”) and strong inflammation occurs (Imko-Walczuk et al., 2009). 
The list of risk factors in developing MM includes pale skin, blond or red hair, numerous 
freckles and tendency to burn and tan poorly, presence of more than 50 acquired nevi, more 
than five dysplastic (atypical, Clark's) nevi, large congenital nevi, nevi larger than 6 mm, 
PUVA therapy, tendency to sunburn and tan poorly, use of tanning salons, Xeroderma 
pigmentosum, immunosuppression, chemical exposures, scars, Marjolin's ulcer, and genetic 
factors (Bandarchi et al., 2010; Halpern et al., 1991). 
2. Diagnosis of melanoma malignum 
2.1 Routine diagnostic methods and prognostic factors 
During the past 30 years, there has been significant evolution in the diagnosis of early 
melanoma. Several factors have contributed to a marked improvement in detection of 
cutaneous melanomas at an early, curable stage (Rigel & Carucci, 2000). Early detection of 
MM remains the key factor in lowering mortality from this cancer. Recognizing the 
importance of this issue 25 years ago, Rigel’s group at New York University published the 
mnemonic “ABCD” to facilitate the early diagnosis of melanoma (Rigel et al., 2010). The 
ABCD rule of typical MM means: asymmetry, border irregularity, colour variegation, 
diameter more than 6 mm. However, many exceptions may occur as they may do in other 
medical disciplines. Studies have demonstrated the usefulness of this paradigm in 
enhancing early melanoma diagnosis as a part of clinical examinations, mass screenings, 
and public education programs. Even though dermascopy, even in the hands of a relatively 
inexpert practitioner, may show high diagnostic accuracy and boost the clinical suspicion in 
diagnosing MM; however, the definitive diagnosis is confirmed done by biopsy. 
The clinicopathological stage of the melanoma patients can determine by pathological 
evaluation of the primary lesion and of the dissected lymph nodes, as well as by routine 
examinations (lactate dehydrogenase test, chest X-ray, ultrasound of the abdominal cavity, 
and computed tomography (CT) or positron emission tomography combined with CT) 
(Neila & Soyer, 2011).  
There are three classes of adverse prognostic factors in melanoma: pathological, clinical, and 
other factors including genetic alteration (Bataille, 2000). Among others the first group 
includes increasing the Breslow thickness and Clark level. In 1969, Clark et al. proposed 
staging criteria for lesions on the basis of skin invasion levels (Clark et al., 1969). 
Subsequently, Breslow evidenced the importance of the primary melanoma thickness in 
millimetres, and this index became one of the most important prognostic indicators, in 
association with data on ulceration, mitosis, regression, microscopic satellites, 
histopathologic subtype, and presence of vertical growth phase (Breslow & Macht, 1977; 
Byers & Bhawan 1998; Clemente et al., 1996). Proliferation of the primary melanoma as 
defined by the mitotic rate was identified as a powerful and independent predictor of 
survival. As a result, primary tumour mitotic rate is now a required element for the seventh 
edition melanoma staging system. Multiple thresholds of mitotic rate were examined 
statistically, and the most significant correlation with survival was identified at a threshold 
of at least 1/mm2. Data from the American Joint Committee on Cancer Melanoma Staging 
Database demonstrated a highly significant correlation between increasing mitotic rate and 
declining survival rates. In a multifactorial analysis of 10,233 patients with clinically 
localized melanoma, mitotic rate was the second most powerful predictor of survival, after 
tumour thickness (Balch, et al., 2009). Clinical adverse factors include increasing age, male, 
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location of the lesion, and metastasis. Moreover, regional lymph node (Sentinel) status has 
emerged as an accurate method for evaluating the draining lymph node basin, allowing for 
the generation of valuable prognostic information (Mraz-Gernhard et al., 1998). Sentinel 
lymph node biopsy became a compulsory phase for patients with tumour thickness > 1 mm 
(Patnana, et al., 2011; Petrescu, et al., 2010). Beside routine clinical follow-up with the 
unaided eye additional techniques are being used to follow these high risk patients 
sequentially. Recently, there is a need for more studies to diagnose and monitor MM 
patients in any different clinical stages (as far as possible) with non-invasive methods. 
2.2 New diagnostic method: A DSC technique 
Differential Scanning Calorimetry (DSC) is a thermoanalytical technique which monitors 
small heat changes between a sample and reference. The technique was developed by 
Watson and O'Neill in 1960 (Watson & O’Neill, 1966). For biological samples, a dilute 
aqueous solution of a biomolecule is loaded into a sample chamber and a matched reference 
buffer loaded into a reference chamber. Both chambers are heated, and as the temperature 
increases, thermally-induced processes occurring in the sample cell result in heat either 
being absorbed or released. This creates a thermal imbalance between the sample and 
reference chambers which is compensated for by electrically-powered feedback heaters. This 
electrical power output is directly proportional to the apparent heat capacity of the sample 
and reference solutions and is the raw data recorded during a DSC experiment (Biltonen & 
Freire, 1978; Brandts & Lin, 1990).  
The DSC thermogram, is an unique signature for bio-molecules reflecting the normal or 
pathomorphological changes under given solution conditions. Therefore, DSC technique 
allows demonstrating the thermal consequences of conformation changes in different bio-
molecules (Zielenkiewicz, 2011). Moreover, DSC is useful method to evaluate local and 
global conformation changes in the structure of different tissue elements not only in the 
animal experiences, but in the orthopaedic and traumatologic, surgical, oncological and 
dermatological clinical studies (Ferencz, et al., 2011; Szántó & Lőrinczy, 2011; Wiegand, et 
al., 2011). 
Depending on the structural nature of the protein, denaturation might reflect the 
independent melting of individual domains within the tertiary structure of the protein 
resulting in a complex thermogram with multiple transitions. A primary DSC thermogram 
is an extensive property of a protein solution and is therefore directly proportional to the 
mass of protein in solution. For plasma, assuming there are no significant interactions 
between the plasma proteins, the DSC thermogram will reflect the melting of a complex 
mixture of proteins with the observed thermogram representing the sum of the individual 
protein thermograms weighted according to their mass in solution (Garbett, et al., 2009). The 
high sensitivity of DSC towards binding interactions means that dramatic shifts in DSC 
thermograms can result from binding interactions. This represents an intrinsic advantage of 
the DSC method over other methods applied to the study of the plasma protein, such as 
electrophoresis and mass spectrometry.  
The result of a DSC experiment is a curve of heat flux versus temperature or versus time. As 
the temperature increases the sample eventually reaches its melting temperature (Tm). The 
melting process results in an endothermic peak in the DSC curve. A biomolecule in solution is 
in equilibrium between the native (folded) conformation and its denatured (unfolded) state. 
The higher the thermal transition midpoint, when 50% of the biomolecules are unfolded, the 
more stable the molecule. The ability to determine Tm temperatures (T1, T2) and enthalpies 
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makes DSC a valuable tool in producing phase diagrams for various chemical systems. T1/2 
indicates the cooperatively of thermal domens. The calorimetric enthalpy (ΔH) is an absolute 
measurement of the heat energy uptake, given by the area under the transition peak. It 
depends on the total amount of (active) protein in the calorimeter cell (Fig. 1.).  
Recently, numerous articles confirmed that DSC is widely used as a new diagnostic 
method for detection of diseases’ seriousness, and as an applicable technique during 
monitoring of patients. Garbett and co-workers demonstrated in these calorimetric studies 
average thermograms for individuals diagnosed with various diseases (Lyme disease, 
rheumatoid arthritis) and cancers (endometrial, ovarian, lung), among others in 5 patients 
with MM. 
These data suggest that each type of cancer or disease may have a characteristic signature in 
their thermogram (Garbett, et al., 2007, 2009; Michnik, 2011). This method is based on the 
biophysical technique of DSC, which monitors heat changes in a sample as a function of 
temperature. Analysis of plasma proteins using DSC is therefore based on an entirely 
different physical property than those of size, charge and chemical interactions that are 
utilized by the techniques of electrophoresis, mass spectrometry and immunochemistry, 




Fig. 1. DSC curve of human healthy control blood plasma 
Transition temperatures: T1: beginning of denaturation, T2: end of denaturation;  
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This chapter will discuss the application of a DSC approach as a new diagnostic method for 
MM diagnosis and monitoring of patients with different clinical stages. 
2.2.1 DSC examination of blood plasma of MM patients 
In this study the primary melanoma and the sentinel lymph nodes painted with patent blue 
and labelled with 99mTc radiotracer were removed from 36 white adult patients (26 men and 
10 women; median age, 61.3 years), who had histopathologically diagnosed operable MM. 
Surgery and follow-up were made in the Department of Dermatology, Venereology and 
Oncodermatology of the University Pecs, Hungary. MM was located on the head and neck 
(11%), on trunk (39%), on the upper limbs (27%), and on the lower limbs (23%). Regional 
lymph nodes were positive in 12 patients, while distant metastases (lung, brain) were 
diagnosed in 5 cases. From histopathological parameters tumour thickness were evaluated 
according to Breslow’s, which is a prognostic factor of MM. This parameter changed from 
0.5 mm to 8.3 mm in our patients. Clark's level is a related staging system, used in 
conjunction with Breslow's depth, which describes the level of anatomical invasion of the 
melanoma in the skin. Clark's level has prognostic significance only in patients with very 
thin (Breslow’s depth <1 mm) melanomas. Invasion value was between Clark level II and IV 
in this study. The protocol was approved by regional ethical committee of Pecs University 
(27.06.2008/3220). 
Peripheral blood samples of healthy controls (n=10) and preoperatively from MM patients 
(n=35) were collected and plasma components were analyzed by DSC technique. The 
thermal unfolding of the human plasma components were monitored by SETARAM Micro 
DSC II calorimeter. All experiments were conducted between 0 and 100 ◦C. The heating rate 
was 0.3 K/min in all cases. Conventional Hastelloy batch vessels were used during the 
denaturation experiments with 850μL sample volume in average. Reference sample was 
contained normal saline (0.9% NaCl). The sample and reference samples were equilibrated 
with a precision of ±0.1 mg. There was no need to do any correction from the point of view 
of heat capacity between sample and reference samples. The repeated scan of denatured 
sample was used as baseline reference, which was subtracted from the original DSC curve. 
Calorimetric enthalpy was calculated from the area under the heat absorption curve by 
using two-point setting SETARAM peak integration. 
Comparison of DSC scans of healthy controls to the curves of cases with regional 
metastases, the DSC measurements showed 2 different thermal domains during the 
denaturation (Fig. 1., Fig. 2.). DSC measurements showed at least two marked different 
thermal domains during the denaturation. The first Tms were only slightly influenced by the 
Breslow’s depth and the Clark level (see Table 1 and 2), but it can be seen a difference in the 
melting enthalpies (Fig. 2.). The second Tms and the calorimetric enthalpy changes 
demonstrated a significant difference of the melanoma depth dependence in 0.95-8 mm 
range and in Clark levels of II-IV (Fig. 2. as well as Table 1. and 2). These thermal 
parameters have been changed significantly in comparing with the control samples which 
were: Tms 56 ºC and 63 ºC, H~1.5 J/g. In the pathologic samples and in the progress of the 
decease one can separate a third thermal component between the first and second Tm (Fig. 
2.). It is at around 62 ºC, and it is shifted to higher temperature in case of regional metastasis. 
In cases of MM with distal metastases plasma denaturation exhibited an increase in second 
Tm, but a decrease in the calorimetric enthalpy (Fig. 2.). 
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Fig. 2. DSC scans of human plasma in healthy controls, in MM patients with regional or 
distant metastases. Downward deflection represents endotherm process. (Black line: control, 
red line: MM with regional metastasis, blue line: MM with distant metastasis) 
 






Control (n=10)  56 ± 0.2 63.3 ± 0.3 1.53 ± 0.02 
Breslow’s depth (mm)    
0.5-1.0  (n=7) 55.8 ± 0.2 64.1 ± 0.3 1.13 ± 0.02 
1.1-1.5  (n=2) 56.3 ± 0.3 63.5 ± 0.02 1.61 ± 0.01 
1.6-2.0  (n=2) 55.75 ± 0.3 67.15 ± 0.4 1.3 ± 0.02 
2.1-3.0  (n=5) 56.16 ± 0.2 62.18 ± 0.02 1.45 ± 0.03 
3.1-4.0  (n=3) 55.8 ± 0.04 63.2 ± 0.2 1.37 ± 0.02 
4.1-6.0  (n=2) 55.7 ± 0.2 63.9 ± 0.4 1.25 ±  0.01 
6.1-8.5  (n=3) 55.8 ± 0.01 64.5 ± 0.1 1.23 ± 0.04 









I. (n=2) 55.2 ± 0.3 64.6 ± 0.1 1.14 ± 0.02 
II. (n=1) 55.8 ± 0.03 63 ± 0.01 1.45 ± 0.04 
III. (n=10) 55.7 ± 0.4 64.63 ± 0.2 1.286 ± 0.03 
IV. (n=12) 56.05 ± 0.2 60.4 ± 0.02 1.43 ± 0.03 
Table 2. DSC data according to Clark level of melanoma 
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Malignant melanoma is one of the most aggressive malignancies in human and is 
responsible for almost 60% of lethal skin tumours. Its incidence has been increasing in white 
population in the past two decades. Moreover, metastatic MM is an incurable disease with 
high mortality rate. Patients with metastatic disease have an average survival of <1 year. 
This high mortality rate is largely the result of the resistance to chemotherapy and 
radiotherapy (Palmieri, et al., 2009; Uong & Zon, 2010).  
Although for most tumours, diameter is a powerful prognostic attribute, this is not so for 
melanomas, which can be very broad and yet have a good prognosis. This is because most 
melanomas have an extensive in situ or superficially invasive component that does not 
contribute to metastatic potential. It is therefore misleading and not recommended to 
report the breadth of a melanoma in a pathology diagnosis (Elder, 2011). The extent of 
penetration of melanoma cells into the skin was recognized as a better predictor of 
survival than breadth in a few early studies and was first codified into a powerful model 
in 1967 by Clark and co-workers. The disease was classified into intraepidermal (Clark 
level I), invades papillary dermis (Clark level II), fills papillary dermis (Clark level III), 
invades reticular dermis (Clark level IV), and invades subcutaneus fat (Clark level V) 
(Clark et al., 1969). Clark's level is a related staging system, used in conjunction with 
Breslow's depth, which describes the level of anatomical invasion of the melanoma in the 
skin. In 1970, Breslow described a simple system for measuring the thickness of 
melanomas. The Breslow thickness is determined by measuring from the top of the 
granular layer of the overlying skin, or from the base of an overlying ulcer, to the deepest 
invasive melanoma cell. Clark's level has prognostic significance only in patients with 
very thin (Breslow’s depth <1 mm) melanomas.  
Adequate resection of the specimens and sentinel lymph node biopsies are important factors 
in management of MM. But, there is no definite proof that longevity of patients is affected 
by routine laboratory tests (Bandarchi et al., 2010). New diagnostic methods in development 
and progression of MM could be helpful to identify the molecular profiles underlying 
aggressiveness, clinical behaviour, and response to therapy as well as to better classify the 
subsets of melanoma patients with different prognosis and/or clinical outcome. The 
human plasma proteome holds great promise as a convenient specimen for disease 
diagnosis and therapeutic monitoring. Moreover, blood samples may be easily obtained 
from patients by minimally invasive, safe procedure. The novel calorimetric assays are 
described that provides a new window through which to view the properties of the 
human plasma proteome (Anderson, N.L. & Anderson, N.G., 2002; Bruylants, et al., 2005; 
Ebert, et al., 2006). 
This study investigated the thermal changes of human blood plasma components in 
melanoma patients with or without regional lymph node metastases by DSC. Overview 36 
patients’ thermograms, we observed their individual characteristics compare to healthy 
controls. Similar observations have been described by Garbett et al. in their important 
calorimetric studies, where demonstrated average thermograms for individuals diagnosed 
with various diseases (Lyme disease, rheumatoid arthritis) and cancers (endometrial, 
ovarian, lung), among others in 5 patients with MM. These data suggest that each type of 
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In the present study, DSC scan of healthy controls and the curves of MM cases showed 2 
different thermal domains during the denaturation. Moreover, patients’ thermograms are 
shifted towards higher denaturation temperatures. These changes were confirmed in the 
literature, where the average thermogram was obtained from duplicate DSC runs on 
samples from 100 healthy individuals and from 5 MM patients’ sample also. Moreover, the 
disease thermograms are apparently localized in a higher temperature range. These unique 
appearances present a key utility of this technology as a diagnostic method (Garbett, et al., 
2008). 
Examination of DSC data in different clinical stages of MM patients should observed closed 
correlation with melanoma thickness and the extent of regional invasion. The first Tm was 
slightly influenced by the Breslow’s depth and the Clark level (I. and III.). But, the second Tm 
and the calorimetric enthalpy changes demonstrated the melanoma depth dependence in 
0.95-8 mm range and in Clark levels of II-IV. The surprising jump out of all thermal data in 
1.1-2.0 mm Breslow’s depth range as well as the opposite change in the tendency of Tm2 and 
H need further investigation with increased number of patients and with finer filtering. 
The same could be the conclusion in case of Clark level II. and IV. 
These facts are important for many reasons: DSC measurement is suitable not only to clear 
skin cancer diagnosis, but to separate the different stages of MM patients and to monitor the 
actual stage of individual’s disease. However, there are no data in the literature indicating 
the possible diagnostic and staging method of human blood plasma by DSC in MM patients. 
Similar findings have been described in another report, where applied the DSC method to 
investigate its utility for disease staging. Gynaecologic oncology samples analyzed by the 
method yielded progressively shifted thermograms charting the advance of cervical cancer 
from pre-invasive cervical lesions through each stage of invasive carcinoma. The distinction 
between normal and high-grade squamous intraepithelial lesions is significant and indicates 
the utility of the DSC method for the rapid screening of cervical cancer (Garbett, et al., 2009). 
The exact explanations of these results are not yet known. However, DSC analysis of plasma 
from diseased individuals revealed significant changes in the thermogram which are 
suggested to result not from changes in the concentration of the major plasma proteins but 
from interactions of small molecules or peptides with these proteins. 
From clinical perspective, MM is generally considered to be a highly aggressive cancer, 
although a small subset of patients with metastatic melanoma has a relatively indolent 
disease course (Tsao, et al., 2004). Histologically, mitoses are frequently apparent in sections 
of melanoma tumours and staining for proliferative markers such as Ki67 is usually positive 
(Ohsie, et al., 2008). In the earliest descriptions of melanoma, the disease was regarded as a 
tumour mass that developed in the skin and was often surrounded by satellites at the time 
of presentation. A few studies recognized that more superficial melanomas have a better 
prognosis.  
DSC thermograms of MM cases with distant metastases are shifted more towards higher 
denaturation temperatures. No other DSC data in the literature in MM patient with 
metastatic phase. But, there was a progressive shift of the thermogram to higher 
denaturation temperatures in cases of invasive cervical cancer compare to high-grade 
squamous intraepithelial lesions. The thermograms appear to be distinct from all the other 
diseases and unique for high-grade squamous intraepithelial lesions and invasive cervical 
cancer. The distinction between normal and high-grade squamous intraepithelial lesions is 
significant and indicates the utility of the DSC method for the rapid screening of cervical 
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cancer. A more detailed analysis of the data has revealed a progressively shifted 
thermogram for each stage of the disease (Garbett, et al., 2009). 
In summary, this is the first report examined thermal changes by DSC on human blood 
plasma in MM patients with different clinical stages. Blood collection is a simple procedure 
and convenient to perform, and the DSC thermogram confirmed unique signature for 
human plasma components reflecting the normal, the pathomorphological changes and 
staging differences in melanoma patients. Further studies are needed to elucidate these 
relationships, but this preliminary study indicates great potential for the application of DSC 
as a clinical diagnostic tool, for example during disease grading and staging processes. 
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